Showing results (121-130 of 227) with videos related to
Sort By:
Pageof 23
Platelets|November 18, 2008
Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic targetPaul A Gurbel, Mark J Antonino, Kevin P Bliden, et al.Journal of Experimental Pharmacology|December 15, 2021
Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One AgentUdaya S Tantry, Karsten Schror, Eliano Pio Navarese, et al.American Heart Journal|July 12, 2011
The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studiesKevin P Bliden, Udaya S Tantry, Robert F Storey, et al.The American Journal of Cardiology|October 23, 2016
Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes MellitusPaul A Gurbel, Kevin P Bliden, Rahul Chaudhary, et al.Journal of Thrombosis and Thrombolysis|July 12, 2017
Central aortic pulse pressure, thrombogenicity and cardiovascular riskGailing Chen, Kevin P Bliden, Rahul Chaudhary, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 11, 2016
Risk factors associated with plasma omega-3 fatty acid levels in patients with suspected coronary artery diseaseRahul Chaudhary, Katayoon Saadin, Kevin P Bliden, et al.Expert Review of Clinical Pharmacology|August 8, 2014
Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirinMartin G Gesheff, Christopher J Franzese, Kevin P Bliden, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 9, 2021
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?Paul A Gurbel, Kevin P Bliden, Jerrold H Levy, et al.Journal of Clinical Medicine|July 2, 2021
Effects of Monotherapy with Clopidogrel vs. Aspirin on Vascular Function and Hemostatic Measurements in Patients with Coronary Artery Disease: The Prospective, Crossover I-LOVE-MONO TrialHyun-Woong Park, Min-Gyu Kang, Jong-Hwa Ahn, et al.Journal of the American Heart Association|October 22, 2014
Influence of race and sex on thrombogenicity in a large cohort of coronary artery disease patientsEli I Lev, Kevin P Bliden, Young-Hoon Jeong, et al.Pageof 23